Study rejects link between digoxin, mortality risk in A-fib patients

04/18/2013 | MedPage Today (free registration)

Taking digoxin does not increase the risk of mortality, hospital admissions or incident nonfatal arrhythmia in patients with atrial fibrillation, according to a study published online in the European Heart Journal. Researchers analyzed data from the AFFIRM study and found no significant difference in rate of all-cause death between digoxin users and nonusers.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC